Top cited articles
Acceptance Rate:
40%
Time to first decision with review:
32 days*
Acceptance to publication:
17 days*
Impact Factor:
3.9
Citescore:
5.0
2021 DORIS definition of remission in SLE: final recommendations from an international task force
Type 1 interferon status in systemic lupus erythematosus: a longitudinal analysis
Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies
Safety profile of anifrolumab in patients with active SLE: an integrated analysis of phase II and III trials
Living with systemic lupus erythematosus in 2020: a European patient survey
Immunogenicity of the third and fourth BNT162b2 mRNA COVID-19 boosters and factors associated with immune response in patients with SLE and rheumatoid arthritis
Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case-control study over 10 years
Quinolinic acid, a kynurenine/tryptophan pathway metabolite, associates with impaired cognitive test performance in systemic lupus erythematosus
Effects of targeting the transcription factors Ikaros and Aiolos on B cell activation and differentiation in systemic lupus erythematosus
LLDAS is an attainable treat-to-target goal in childhood-onset SLE
Frequency, severity and costs of flares increase with disease severity in newly diagnosed systemic lupus erythematosus: a real-world cohort study, United States, 2004-2015
Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria
ANA-positive primary immune thrombocytopaenia: a different clinical entity with increased risk of connective tissue diseases
Impact of severe infections in SLE: an observational study from the Spanish national registry
Achieving remission or low disease activity is associated with better outcomes in patients with systemic lupus erythematosus: a systematic literature review
Association between systemic lupus erythematosus and disruption of gut microbiota: a meta-analysis
Apolipoprotein L1 risk genotypes in Ghanaian patients with systemic lupus erythematosus: a prospective cohort study
Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus
Hydroxychloroquine PK and exposure-response in pregnancies with lupus: the importance of adherence for neonatal outcomes
Breastfeeding in women with rheumatic diseases